Skip to content
Hindustan Bio Sciences logo

Hindustan Bio Sciences

532041 BSE
₹7.04 up 0.24 (3.53%)
Market Cap
₹7.18 Cr

Hindustan Bio Sciences (HINDBIO) share price was ₹6.80 at the 28 Oct 2026 close; market capitalisation ₹6.93 Cr; sector Information Technology. The share price rose 4.6% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was under ₹0.01 Cr, against ₹0.32 Cr a year earlier and net profit was −₹0.11 Cr, against ₹0.01 Cr a year earlier (compared with Jun 2025). Promoters held 12.19% of Hindustan Bio Sciences in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 41/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹6.80 0.00 0.00% 1Y

Key Fundamentals

MicrocapIT - SoftwareInformation Technology
Market Cap
₹7.18 Cr
EBITDA
−₹10.00 L
Return on Equity
-9.6%
Return on Capital Employed
-2.46%
Debt to Equity
2.83
Book Value
₹0.81
EPS (TTM)
−₹0.21
52W High
₹9.92
52W Low
₹5.00

Price-based figures as of 29 Oct 2026, 11:37 IST · EPS basis: Standalone · TTM

Peer Comparison

Information Technology › Software Products

Oracle Financial Services Software
₹10,143.0025.8688,328 Cr11.504.03%33.72%43.24%9,338 Cr3,414 Cr
Tanla Platforms
₹624.9015.558,288 Cr3.042.07%20.46%25.19%4,919 Cr532 Cr
CE Info Systems
₹828.0032.904,539 Cr5.020.42%14.81%20.72%551 Cr139 Cr
Capillary Technologies
₹520.2597.984,141 Cr4.050.00%5.12%5.43%855 Cr42 Cr
Mobavenue AI Tech
₹269.9558.942,087 Cr23.030.57%32.41%33.84%248 Cr35 Cr
Ramco Systems
₹533.4548.102,006 Cr5.740.00%11.89%11.90%725 Cr42 Cr
Hindustan Bio Sciences (this company)
₹7.04—7 Cr8.690.00%-9.60%-2.46%0 Cr-0 Cr
Median 7 companies₹533.4540.504,141 Cr5.740.42%14.81%20.72%725 Cr42 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

41 Weak
Overall score

Data confidence 88/100

Category scores

Quality Average 49
Returns, margins, earnings quality 22% weight
Valuation Weak 39
Cheap vs sector & own history 24% weight
Growth Poor 6
Sales & profit trajectory 9% weight
Financial Health Poor 23
Solvency, leverage, coverage 9% weight
Momentum Weak 41
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Debtor days have improved from 125 to 24.7 days.

Weaknesses

6
  • Stock is trading at 8.67 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -6.40% over past five years.
  • Promoter holding is low: 12.2%
  • Company has a low return on equity of 5.22% over last 3 years.
  • Company might be capitalizing the interest cost

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bearish

Bearish
12
Neutral
7
Bullish
0

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
-12.5% lower than 3Y

change over 1 year

Net Income Growth
-200% lower than 3Y

change over 1 year

Cash Flow Change
833%

change over 1 year

EBITDA Margin Change
-164%

change over 1 year

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0.32
0.32
0.39
0.41
0.41
0
0.38
0.32
0
0.38
0
0
Expenses
0.12
0.26
0.26
0.35
0.34
0.34
0.04
0.28
0.32
0.06
0.31
0.11
0.11
Operating Profit
-0.12
0.06
0.06
0.04
0.07
0.07
-0.04
0.1
0
-0.06
0.07
-0.11
-0.11
OPM %
—
18.75%
18.75%
10.26%
17.07%
17.07%
—
26.32%
0%
—
18.42%
—
—
Other Income
0
0.01
0.01
0
0.01
0.01
0
0.01
0.01
0.01
0.02
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0.01
0
0
PBT
-0.12
0.07
0.07
0.04
0.08
0.08
-0.04
0.11
0.01
-0.05
0.08
-0.11
-0.11
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
-0.12
0.07
0.07
0.04
0.08
0.08
-0.04
0.11
0.01
-0.06
0.08
-0.12
-0.11
EPS (₹)
-0.12
0.07
0.07
0.04
0.08
0.08
-0.04
0.11
0.01
-0.06
0.08
-0.12
-0.11
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0.75
1.26
1.01
1.03
3.56
1.94
1.03
0.43
0.92
1.05
0.81
0.74
0.38
Expenses
1.97
1.38
1.48
3.38
3.43
1.8
1.97
0.94
0.95
0.99
0.71
0.75
0.59
Operating Profit
-1.22
-0.12
-0.47
-2.35
0.13
0.14
-0.94
-0.51
-0.03
0.06
0.1
-0.01
-0.21
OPM %
-162.67%
-9.52%
-46.53%
-228.16%
3.65%
7.22%
-91.26%
-118.6%
-3.26%
5.71%
12.35%
-1.35%
-55.26%
Other Income
-0.01
-1.92
0
0.09
0
0
0
0
0
0
0
-0.05
0.03
Interest
0.03
0.03
0.01
0
0.01
0.01
0.01
0
0
0
0
0
0
Depreciation
0.18
0.01
0.01
0.01
0.01
0.01
0.01
0
0.01
0.01
0
0.02
0.01
PBT
-1.44
-2.08
-0.49
-2.27
0.11
0.12
-0.96
-0.51
-0.04
0.05
0.1
-0.08
-0.19
Tax %
0.69%
0%
0%
0%
0%
33.33%
-2.08%
0%
0%
0%
0%
0%
—
Net Profit
-1.46
-2.09
-0.49
-2.28
0.11
0.08
-0.94
-0.52
-0.04
0.06
0.1
-0.08
-0.21
EPS (₹)
-1.42
-2.04
-0.48
-2.22
0.11
0.08
-0.92
-0.51
-0.04
0.06
0.1
-0.08
-0.21
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
10.25
10.25
10.25
10.25
10.25
10.25
10.25
10.25
2.05
2.05
2.05
2.05
Reserves
-3.34
-5.43
-5.92
-8.2
-8.09
-8.01
-8.95
-9.46
-1.3
-1.25
-1.15
-1.22
Borrowings
0.97
0.94
1.3
1.57
3.37
2.6
1.86
2.17
2.46
2.56
2.51
2.35
Other Liabilities
0.17
0.12
0.24
0.09
0.1
0.71
0.32
0.02
0.08
0.01
0.01
0.02
Total Liabilities
8.05
5.88
5.87
3.71
5.63
5.55
3.48
2.98
3.29
3.37
3.42
3.2
Fixed Assets
0.08
0.07
0.06
0.06
0.06
0.05
0.04
0.04
0.03
0.03
0.03
0.01
CWIP
1.92
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
6.05
5.81
5.81
3.65
5.57
5.5
3.44
2.94
3.26
3.34
3.39
3.19
Total Assets
8.05
5.88
5.87
3.71
5.63
5.55
3.48
2.98
3.29
3.37
3.42
3.2
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.27
0.46
-0.16
-0.23
-1.32
0.82
0.75
-0.34
-0.05
-1.41
0.03
0.28
Investing
0
0
0
0
-0.01
0
0
0
0
0
0
-0.01
Financing
0.3
-0.63
0.18
0.21
1.5
-0.81
-0.93
0.34
0.05
1.43
-0.05
-0.16
Net Cash Flow
0.03
-0.17
0.01
-0.02
0.17
0.01
-0.18
-0.01
0
0.03
-0.02
0.12
Free Cash Flow
-0.27
0.46
-0.16
-0.23
-1.33
0.82
0.75
-0.34
-0.05
-1.41
0.03
0.27
CFO/OP
22
-383
34
10
-1,015
600
-78
67
167
-2,350
30
-2,800
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
156
136
170
113
171
256
220
119
179
153
198
24.66
Inventory Days
25.08
0
0
51.23
13.89
95.46
0
0
0
0
0
0
Days Payable
39.01
—
—
44.82
7.58
185
—
—
—
—
—
—
Cash Conversion Cycle
142
136
170
120
178
166
220
119
179
153
198
24.66
Working Capital Days
112
-63.73
-192
-170
85.1
86.55
-149
-501
-226
313
442
306
ROCE %
-16.4%
-1.91%
-8.43%
-49.08%
2.62%
2.51%
-23.75%
-16.67%
-1.3%
1.52%
2.95%
-0.91%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Hindustan Bio Sciences insights

61 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

Public81.07%Others6.74%Promot.12.19%As ofSep 2026

Documents

Frequently Asked Questions about Hindustan Bio Sciences

What does Hindustan Bio Sciences Ltd do?
Incorporated in 2000, Hindustan Biosciences Ltd manufactures & sells pharmaceutical products.[1]
Where is Hindustan Bio Sciences Ltd (HINDBIO) listed?
Hindustan Bio Sciences Ltd trades under code 532041 on the BSE.
Which sector does Hindustan Bio Sciences Ltd belong to?
Hindustan Bio Sciences Ltd is classified under the Information Technology sector, in the Software Products industry.
What is the market capitalisation of Hindustan Bio Sciences Ltd?
Hindustan Bio Sciences Ltd has a market capitalisation of ₹7.18 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Hindustan Bio Sciences Ltd?
Over the last 52 weeks Hindustan Bio Sciences Ltd has traded between ₹5 and ₹9.92 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Hindustan Bio Sciences Ltd?
Hindustan Bio Sciences Ltd reported a return on equity of -9.60%. Its debt-to-equity ratio is 2.83.

Company Information

Incorporated in 2000, Hindustan Biosciences Ltd manufactures & sells pharmaceutical products.[1]

Website hindustanbiosciences.in
Face Value ₹ 2
Shares Outstanding 1,01,92,024

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/532041.md for Hindustan Bio Sciences Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More IT Software stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month